Makindo Medical Notes.com |
|
---|---|
Download all this content in the Apps now Android App and Apple iPhone/Pad App | |
MEDICAL DISCLAIMER:The contents are under continuing development and improvements and despite all efforts may contain errors of omission or fact. This is not to be used for the assessment, diagnosis or management of patients. It should not be regarded as medical advice by healthcare workers or laypeople. It is for educational purposes only. Please adhere to your local protocols. Use the BNF for drug information. If you are unwell please seek urgent healthcare advice. If you do not accept this then please do not use the website. Makindo Ltd |
Interstitial lung disease (ILD) refers to a group of disorders that cause progressive scarring (fibrosis) of lung tissue. This can affect oxygenation.
Cause | Clinical Diagnosis | Investigations | Management |
---|---|---|---|
Idiopathic Pulmonary Fibrosis (IPF) | Gradual onset of dry cough and dyspnoea, fine inspiratory crackles, clubbing | High-resolution CT (HRCT) scan showing honeycombing and reticular patterns, pulmonary function tests (PFTs) | Antifibrotic agents (e.g., Pirfenidone, Nintedanib), pulmonary rehabilitation, oxygen therapy, lung transplantation in advanced cases |
Hypersensitivity Pneumonitis (HP) | Recurrent exposure to organic dust, birds, or mold; symptoms worsen after exposure | HRCT showing ground-glass opacities, poorly defined centrilobular nodules; bronchoalveolar lavage (BAL) showing lymphocytosis | Avoidance of antigen, corticosteroids for acute management, immunosuppressants for chronic cases |
Sarcoidosis | Systemic symptoms (fatigue, weight loss), erythema nodosum, bilateral hilar lymphadenopathy | HRCT showing perilymphatic nodules, non-caseating granulomas on biopsy, elevated serum ACE levels | Corticosteroids (first-line), immunosuppressants (e.g. methotrexate) for refractory cases, monitoring for organ involvement |
Connective Tissue Disease-Associated ILD (e.g., Scleroderma, Rheumatoid Arthritis) | Symptoms of underlying CTD (joint pain, skin thickening), dyspnoea on exertion | HRCT showing ground-glass opacities, reticulations; autoantibody testing (ANA, RF); PFTs showing restrictive pattern | Management of underlying CTD, immunosuppressants (e.g., cyclophosphamide, mycophenolate mofetil), antifibrotic therapy in progressive cases |
Occupational Lung Disease (e.g., Asbestosis, Silicosis) | History of exposure to asbestos, silica, or other industrial dusts; progressive dyspnoea, cough | HRCT showing pleural plaques (asbestosis), nodular opacities (silicosis), lung biopsy if diagnosis is unclear | Removal from exposure, supportive care (oxygen therapy), corticosteroids for symptomatic relief, monitoring for complications like lung cancer |
Drug-Induced ILD | History of use of drugs known to cause ILD (e.g., amiodarone, methotrexate); non-productive cough, dyspnoea | HRCT showing diffuse alveolar damage, eosinophilia in blood or BAL, lung biopsy if diagnosis is unclear | Discontinuation of the offending drug, corticosteroids in severe cases, supportive care, monitoring for resolution or progression |
Radiation-Induced ILD | History of chest radiation therapy, progressive dyspnoea, non-productive cough | HRCT showing fibrosis confined to the radiation field, PFTs showing restrictive pattern | Supportive care, corticosteroids in severe cases, monitoring for progression or resolution |